Northwest & Ethical Investments’s Zymeworks ZYME Stock Holding History
Bought
Maintained
Sold
Other funds holding ZYME
EC
RCMNY
BI
PA
VCM
Northwest & Ethical Investments's ZYME Position: Q1 2026 in Review
Northwest & Ethical Investments increased its Zymeworks (ZYME) stake by 1.7% in Q1 2026, buying an estimated $4.73K and bringing the position to 12,244 shares worth $316K. The position accounts for 0.01% of the portfolio, ranked #449.
Northwest & Ethical Investments first reported a position in ZYME in Q1 2024 and has held it in 9 quarters since. The position peaked at $320K in Q4 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.
- Northwest & Ethical Investments held 12,244 shares of Zymeworks worth $316K as of Q1 2026.
- Northwest & Ethical Investments bought 200 Zymeworks shares in Q1 2026, an estimated $4.73K.
- Zymeworks made up 0.01% of Northwest & Ethical Investments's portfolio in Q1 2026, its #449 holding.
- Northwest & Ethical Investments first reported a position in Zymeworks in Q1 2024 and has held it in 9 quarters since.
- Northwest & Ethical Investments's Zymeworks position peaked at $320K in Q4 2025.
- 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.
Based on Northwest & Ethical Investments's 13F filing for Q1 2026, filed 14 May 2026.